Biotech · Private company
Liquidia Technologies, Inc.
Track this companyFree. Adds Liquidia Technologies, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials76 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- L606Phase 3 · Pulmonary Hypertension Due to Lung Disease (Disorder)ClinicalTrials.gov · fetched Nov 12, 2026
- L606 inhalation suspensionPhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- LIQ861 Inhaled TreprostinilPhase 3 · Primary Pulmonary HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- LIQ861Pulmonary HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- LIQ861 (treprostinil) inhalation powderPulmonary Arterial Hypertension (PAH)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- A Study of Inhaled Treprostinil (LIQ861) in Adults With Pulmonary Arterial Hypertension Transitioning From Oral SelexipagPHASE4 · RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07759804 · fetched Nov 12, 2026
- The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung DiseaseNA · RECRUITING · started Jul 15, 2026ClinicalTrials.gov NCT07561034 · fetched Nov 12, 2026
- A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILDPHASE3 · RECRUITING · started Apr 23, 2026ClinicalTrials.gov NCT07285655 · fetched Nov 12, 2026
- An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PHACTIVE_NOT_RECRUITING · started Dec 28, 2023ClinicalTrials.gov NCT06129240 · fetched Nov 12, 2026
- A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILDPHASE3 · ACTIVE_NOT_RECRUITING · started Aug 1, 2021ClinicalTrials.gov NCT04691154 · fetched Nov 12, 2026
- Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of TreprostinilPHASE3 · ACTIVE_NOT_RECRUITING · started Jul 18, 2019ClinicalTrials.gov NCT03992755 · fetched Nov 12, 2026
- Investigation of the Safety and Pharmacology of Dry Powder Inhalation of TreprostinilPHASE3 · COMPLETED · started Jan 2, 2018ClinicalTrials.gov NCT03399604 · fetched Nov 12, 2026